| 摘要 |
The invention is directed to methods of detecting lung, gastrointestinal tract, and systemic infections by measuring 13C02/12C02 isotopic ratios of gaseous carbon dioxide in exhaled breath samples of a subject after administration of a 13C-isotopically-labeled compound. |
